Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney Disease

被引：1
|
作者：
Ghuman, Jasleen K. [1 ]
Tuttle, Katherine R. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Washington, Div Nephrol, 1959 NE Pacific St,Box 356521, Seattle, WA 98195 USA
[2] Univ Washington, Kidney Res Inst, Sch Med, Div Nephrol, Seattle, WA USA
[3] Univ Washington, Inst Translat Hlth Sci, Sch Med, Seattle, WA USA
[4] Providence Med Res Ctr, Providence Hlth Care, Spokane, WA USA
来源：
KIDNEY360 | 2022年 / 3卷 / 04期
关键词：
diabetes and the kidney; chronic kidney disease prevention; diabetic kidney disease; kidney health; nonsteroidal mineralocorticoid receptor antagonist; FINERENONE; POTASSIUM;
D O I：
10.34067/KID.0007072021
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：744 / 748
页数：5
相关论文
共 50 条
  • [21] Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
    Ningning Wan
    Asadur Rahman
    Akira Nishiyama
    [J]. Journal of Human Hypertension, 2021, 35 : 148 - 156
  • [22] Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
    Wan, Ningning
    Rahman, Asadur
    Nishiyama, Akira
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (02) : 148 - 156
  • [23] Mineralocorticoid receptor antagonists: A new therapeutic option for diabetic kidney disease
    Girerd, Sophie
    Soulie, Matthieu
    Barrera-Chimal, Jonatan
    Jaisser, Frederic
    [J]. M S-MEDECINE SCIENCES, 2023, 39 (04): : 335 - 343
  • [24] Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
    Lee, Seung-Eun
    Kim, Dong-Lim
    Kim, Nan Hee
    [J]. ENDOCRINOLOGY AND METABOLISM, 2023, 38 (01) : 43 - 55
  • [25] Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
    Jonatan Barrera-Chimal
    Ixchel Lima-Posada
    George L. Bakris
    Frederic Jaisser
    [J]. Nature Reviews Nephrology, 2022, 18 : 56 - 70
  • [26] Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects
    Barrera-Chimal, Jonatan
    Lima-Posada, Ixchel
    Bakris, George L.
    Jaisser, Frederic
    [J]. NATURE REVIEWS NEPHROLOGY, 2022, 18 (01) : 56 - 70
  • [27] Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease
    Bayne, Sarah
    Lefevre, James
    Olstinske, Kayla
    Ravindran, Sreenithya
    Munusamy, Shankar
    [J]. ADVANCED BIOLOGY, 2024, 8 (03):
  • [28] Effects of nonsteroidal mineralocorticoid receptor antagonists on kidney of cirrhotic rats
    Huang, Hui-Chun
    Chuang, Chiao-Lin
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2776 - I2777
  • [29] Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy
    Zhao, Min
    Gelize, Emmanuelle
    Levy, Rinath
    Moulin, Alexandre
    Azan, Frederic
    Berdugo, Marianne
    Naud, Marie-Christine
    Guegan, Justine
    Delaunay, Kimberley
    Pussard, Eric
    Lassiaz, Patricia
    Bravo-Osuna, Irene
    Herrero-Vanrell, Rocio
    Behar-Cohen, Francine
    [J]. DIABETES, 2021, 70 (11) : 2668 - 2682
  • [30] Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease
    Shah, Monarch
    Awad, Alaa S.
    Abdel-Rahman, Emaad M.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
12345